Kerala procures 50 doses of monoclonal antibody to combat Nipah

Published On 2018-05-26 08:16 GMT | Update On 2018-05-26 08:16 GMT

Kozhikode: With the help of Indian Council of Medical Research and World Health Organisation, the Kerala government has procured about 50 doses of a monoclonal antibody from Australia to combat Nipah virus, state Health minister K K Shylaja said today.

The antibody will be brought to the state soon, the minister told reporters here.

The Indian Council of Medical Research (ICMR) had written to the Queensland government in Australia asking it to provide the antibody developed there to test if it can "neutralise" the virus in humans.

Speaking to the media after an all party meeting here, the minister said the situation, in the aftermath of the outbreak of the deadly virus, was under control.

It has not spread throughout the state, she said.

Measures have been taken to ensure the safety of the caregivers in hospital, she said, adding, steps have been taken to ensure that the virus does not spread to other areas.

The steps taken by the government to combat the virus were reviewed at the meeting.

Of the 32 samples sent for testing for the virus, all were found negative, health department sources said.

There are 14 confirmed cases of Nipah, of whom 11 have died and three, including a nursing student, are undergoing treatment.

Of the 11 deaths, eight are from Kozhikode and three from neighbouring Malappuram.

The minister said the state was preparing to develop its own anti-viral drug for Nipah with the help of ICMR and community medicine department of Thiruvananthapuram medical college.

Discussions in this regard have begun, she said.

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Medical Dialogues Bureau

Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Kerala procures 50 doses of monoclonal antibody to combat Nipah

Similar News

Odisha CM inugurates 73 Ama Hospitals and dialysis centres in 15 Odisha districts

Unfortunate: PG Orthopedic Student at SSKM Hospital succumbs to dengue

GMC Rajouri gets dermatology wing to treat skin related cancer, diseases

LLRM Medical College: Another doctor booked for beating up patient kin

NHA Posts Decentralized Health Protocol (DHP) on Github platform asks private players to commit

Pregabalin effective in relieving symptoms in Functional Dyspepsia, finds study

JnK starts District Residency Program for PG Medical Students

Arthritis Drug linked to Heart-Related Problems and Cancer by FDA